Gufic Biosciences Limited (BOM:509079)

India flag India · Delayed Price · Currency is INR
276.85
-2.40 (-0.86%)
At close: Mar 9, 2026
-24.04%
Market Cap 27.76B
Revenue (ttm) 8.97B
Net Income (ttm) 500.38M
Shares Out 100.28M
EPS (ttm) 4.99
PE Ratio 55.51
Forward PE n/a
Dividend 0.10 (0.04%)
Ex-Dividend Date Sep 22, 2025
Volume 3,496
Average Volume 1,466
Open 278.00
Previous Close 279.25
Day's Range 270.25 - 304.20
52-Week Range 268.65 - 409.00
Beta -0.14
RSI 35.33
Earnings Date Feb 13, 2026

About Gufic Biosciences

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals. It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (P... [Read more]

Industry Pharmaceutical Preparations
Founded 1970
Employees 1,484
Stock Exchange Bombay Stock Exchange
Ticker Symbol 509079
Full Company Profile

Financial Performance

In fiscal year 2025, Gufic Biosciences's revenue was 8.20 billion, an increase of 1.63% compared to the previous year's 8.07 billion. Earnings were 696.50 million, a decrease of -19.14%.

Financial Statements

News

Gufic Biosciences Ltd (BOM:509079) Q3 2026 Earnings Call Highlights: Resilient Turnover Amid ...

Gufic Biosciences Ltd (BOM:509079) Q3 2026 Earnings Call Highlights: Resilient Turnover Amid Strategic Shifts

18 days ago - GuruFocus

Q3 2026 Gufic Biosciences Ltd Earnings Call Transcript

Q3 2026 Gufic Biosciences Ltd Earnings Call Transcript

18 days ago - GuruFocus

Gufic Biosciences Ltd (BOM:509079) Q2 2026 Earnings Call Highlights: Steady Revenue Growth and ...

Gufic Biosciences Ltd (BOM:509079) Q2 2026 Earnings Call Highlights: Steady Revenue Growth and Strategic International Expansion

3 months ago - GuruFocus

Q2 2026 Gufic Biosciences Ltd Earnings Call Transcript

Q2 2026 Gufic Biosciences Ltd Earnings Call Transcript

3 months ago - GuruFocus

Gufic Biosciences Ltd (BOM:509079) Q3 2025 Earnings Call Highlights: Navigating Profitability ...

Gufic Biosciences Ltd (BOM:509079) Q3 2025 Earnings Call Highlights: Navigating Profitability Challenges Amidst Strategic Expansions

1 year ago - GuruFocus

Q3 2025 Gufic Biosciences Ltd Earnings Call Transcript

Q3 2025 Gufic Biosciences Ltd Earnings Call Transcript

1 year ago - GuruFocus